All product information available on this website is for educational purposes only
2a), whereas the post-injection locomotor activity in the AMPT group was significantly lower than its baseline level, approximately a 50% reduction (Fig
To be, or not to be: functional dilemma of p53 metabolic regulation
Cagrilintide has phase 3 monotherapy data in hand, a dedicated phase 3 programme (RENEW) advancing from Q4 2025, and a second life as the amylin half of CagriSema , the fixed-dose cagrilintide 2.4 mg / semaglutide 2.4 mg combination
The solvent was removed in a speed vac (5 h, 30 C, Concentrator Plus, Eppendorf), and the resulting dried peptides were stored at 20 C until analysis, described in Binding site identification isoDTB analysis section in the Supplementary Information